TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33079883

Group type: EXPERIMENTAL
Intervention: Pupillometry monitoring
Number of subjects: 86

Group type: COMPARATOR
Intervention: SPI monitoring
Number of subjects: 86
Study: 35440450

Group type: EXPERIMENTAL
Intervention: CT-based coronary calcium score (CCS) test
Number of subjects: 800

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 800
Study: 33166179

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 85

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 85
Study: 34610147

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 50
Study: 33393084

Group type: EXPERIMENTAL
Intervention: Iloprost 1 ng/kg/min infusion for 72 hours
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo (equal volume of saline)
Number of subjects: 220
Study: 36323988

Group type: EXPERIMENTAL
Intervention: Glepaglutide 5 mg subcutaneously once weekly for 6 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Glepaglutide 10 mg subcutaneously once weekly for 6 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Glepaglutide 1 mg intravenous infusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Citrulline as a pharmacodynamic biomarker
Number of subjects: 45
Study: 33681357

Group type: EXPERIMENTAL
Intervention: 3D preoperative planning and 3D printed guide
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional operation (2D templates)
Number of subjects: 53
Study: 32743813

Group type: EXPERIMENTAL
Intervention: D-PLEX
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 81
Study: 36122493

Group type: EXPERIMENTAL
Intervention: Multimodal intervention (Geriatric Nursing Theory + Seminar with age simulation suit + student-older adult interaction)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Delayed experimental group (Geriatric Nursing Theory + Seminar without Age simulation suit + student-older adult interaction + Age simulation suit)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (only received theoretical contents of the seminar)
Number of subjects: 70
Study: 33235121

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Yiqi Huayu Jiedu decoction
Number of subjects: 298

Group type: COMPARATOR
Intervention: Chemotherapy combined with placebo
Number of subjects: 298
Study: 34782701

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) for 12 weeks plus fluoxetine
Number of subjects: 94

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT) for 12 weeks plus placebo
Number of subjects: 94
Study: 32139343

Group type: EXPERIMENTAL
Intervention: Sevoflurane (SA group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam-sufentanil based intravenous anesthesia (IA group)
Number of subjects: 0
Study: 36058819

Group type: EXPERIMENTAL
Intervention: Laser Acupuncture Therapy (LAT)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 106
Study: 33952731

Group type: EXPERIMENTAL
Intervention: Fortified crystal salt enriched with iron, iodine, vitamin B12, folic acid, and zinc
Number of subjects: 212

Group type: COMPARATOR
Intervention: Regular non-fortified salt
Number of subjects: 212
Study: 32469318

Group type: EXPERIMENTAL
Intervention: Health information needs classification system
Number of subjects: 1000
Study: 36316843

Group type: EXPERIMENTAL
Intervention: KGC deer antler extract
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34679090

Group type: COMPARATOR
Intervention: Dissemination of written evidence-based practice recommendations
Number of subjects: 833

Group type: COMPARATOR
Intervention: Access to a webinar-based knowledge broker in addition to the recommendations
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Usual practice waitlist control
Number of subjects: 833
Study: 33993302

Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg twice daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg + Lamivudine 150 mg twice daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (Raltegravir alone)
Number of subjects: 36
Study: 32578433

Group type: EXPERIMENTAL
Intervention: Multiple renal clearance estimates
Number of subjects: 154

Group type: COMPARATOR
Intervention: Single renal clearance estimate
Number of subjects: 154
Study: 36123682

Group type: EXPERIMENTAL
Intervention: Test 'A' (with food intake)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Test 'B' (without food intake)
Number of subjects: 24
Study: 34052686

Group type: EXPERIMENTAL
Intervention: Stress task (Trier Social Stress Task; TSST)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No-stress condition
Number of subjects: 31
Study: 32036412

Group type: EXPERIMENTAL
Intervention: CC-486 300 mg daily (Formulation B)
Number of subjects: 0
Study: 35789408

Group type: EXPERIMENTAL
Intervention: Neocate Junior‐Numil®
Number of subjects: 94
Study: 33522102

Group type: EXPERIMENTAL
Intervention: High or escalating dose methotrexate
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 178
Study: 35888692

Group type: EXPERIMENTAL
Intervention: Orthopedic surgeons
Number of subjects: 107

Group type: COMPARATOR
Intervention: Untrained volunteers
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Orthopedic surgeons with more than 100 procedures a year
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Orthopedic surgeons with less surgical experience
Number of subjects: 107
Study: 33845473

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (15 mg/kg initially and then 7.5 mg/kg every 6 h)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intravenous dextrose (control)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 58
Study: 35829783

Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (SQ-LNS) with zinc (0, 5, or 10 mg) or dispersible tablets (5 mg zinc)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (SQ-LNS)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Additional zinc supplementation
Number of subjects: 275
Study: 35503949

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) device
Number of subjects: 125

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 125

Group type: COMPARATOR
Intervention: No anesthesia
Number of subjects: 125
Study: 34875282

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) via telemedicine
Number of subjects: 23
Study: 33657052

Group type: EXPERIMENTAL
Intervention: DLT-SML
Number of subjects: 30
Study: 33371027

Group type: EXPERIMENTAL
Intervention: Location-based remote messaging (tailored-to-place)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard remote messaging
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: More intensive treatment for those not meeting PA goals
Number of subjects: 100
Study: 35987783

Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Electro-Acupuncture (EA)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Warm Acupuncture (WA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 200
Study: 33360708

Group type: EXPERIMENTAL
Intervention: brief cognitive behavior group therapy (bCBGT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: psychoeducational-supportive therapy (PST)
Number of subjects: 50
Study: 32428426

Group type: EXPERIMENTAL
Intervention: Values clarification methods (pros and cons, rating scales)
Number of subjects: 6744

Group type: EXPERIMENTAL
Intervention: Mathematical models showing alignment of options with values
Number of subjects: 6744
Study: 35678616

Group type: EXPERIMENTAL
Intervention: Twice-daily subcutaneous dalteparin
Number of subjects: 38
Study: 32448788

Group type: EXPERIMENTAL
Intervention: Multifactorial diet rich in fiber, MUFA, n-6 and n-3 polyunsaturated fatty acids, polyphenols, vitamins D, E, and C (n=23)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: MUFA diet (n=26)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Multifactorial diet
Number of subjects: 49

Group type: COMPARATOR
Intervention: MUFA diet
Number of subjects: 49
Study: 35800262

Group type: EXPERIMENTAL
Intervention: Qinxiang Qingjie (QXQJ) oral solution
Number of subjects: 231

Group type: COMPARATOR
Intervention: Oseltamivir phosphate granules
Number of subjects: 231
Study: 32062324

Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during standing up from/sitting down on a bench
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during descending stairs
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during passive movement, 10% and 40% loading of the individual one repetition maximum
Number of subjects: 12
Study: 35363128

Group type: EXPERIMENTAL
Intervention: Ferinject (ferric carboxymaltose)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32294054

Group type: EXPERIMENTAL
Intervention: Single-use negative pressure wound therapy (sNPWT)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Traditional negative pressure wound therapy (tNPWT)
Number of subjects: 161
Study: 35618385

Group type: EXPERIMENTAL
Intervention: Coaching intervention focused on the quality of teacher-child interactions
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Coaching intervention
Number of subjects: 281

Group type: COMPARATOR
Intervention: Educator profiles (Average, Strong, Mixed)
Number of subjects: 281
Study: 34987600

Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy combined with monosialotetrahexosylganglioside (GM1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Mild hypothermia therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 90
Study: 33033025

Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise-based intervention comprising a progressive resistance exercise programme two times per week, a protein supplement after exercise, and a home-based walking programme based on daily step counts
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise-based intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard oncological treatment
Number of subjects: 100
Study: 35179506

Group type: EXPERIMENTAL
Intervention: Web-based medical advice authored by a physician
Number of subjects: 2305

Group type: EXPERIMENTAL
Intervention: Web-based medical advice presented with an objective tone
Number of subjects: 2305

Group type: COMPARATOR
Intervention: Discussion forum format
Number of subjects: 2305

Group type: COMPARATOR
Intervention: Article format
Number of subjects: 2305

Group type: EXPERIMENTAL
Intervention: Medical skepticism
Number of subjects: 2305
Study: 36083249

Group type: EXPERIMENTAL
Intervention: Mobile application tailored to Vietnamese cultural context, sending three messages per week
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control group mobile application sending general maternal and child health care messages
Number of subjects: 568
Study: 32062801

Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis (CAD) system based on convolutional neural network (CNN)
Number of subjects: 149
Study: 35964368

Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation (PR) exercise training program
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study: 33902306

Group type: EXPERIMENTAL
Intervention: Neuropathic pain at three months post-injury
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Neuropathic pain at six months post-injury
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Chronic pain without neuropathic characteristics at three months post-injury
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Chronic pain without neuropathic characteristics at six months post-injury
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Physical disability associated with neuropathic pain at six months
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Quality of life associated with neuropathic pain at six months
Number of subjects: 1547
Study: 32844185

Group type: EXPERIMENTAL
Intervention: Antenatal multiple micronutrient (MM) supplementation
Number of subjects: 333

Group type: COMPARATOR
Intervention: Maternal status (1-SD increment)
Number of subjects: 333
Study: 34775830

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dupilumab
Number of subjects: 0
Study: 33275804

Group type: EXPERIMENTAL
Intervention: Modern board and card games (n=6 in pilot study, n=12 in main study)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Modern board and card games (n=12 in main study)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standardized paper-and-pencil cognitive tasks (n=15 in main study)
Number of subjects: 49
Study: 32183423

Group type: EXPERIMENTAL
Intervention: Whey proteins
Number of subjects: 8

Group type: COMPARATOR
Intervention: Maltodextrins
Number of subjects: 8
Study: 34748774

Group type: COMPARATOR
Intervention: 200 mg mirikizumab IV every 4 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: 600 mg mirikizumab IV every 4 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: 1000 mg mirikizumab IV every 4 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: IV-C (continuation of mirikizumab IV treatment)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: 300 mg mirikizumab SC every 4 weeks
Number of subjects: 191
Study: 33234019

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (0.1 g·kg‐1·d‐1)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (0.1 g·kg‐1·d‐1)
Number of subjects: 38
Study: 33371627

Group type: EXPERIMENTAL
Intervention: AI triaging model
Number of subjects: 8005
Study: 35970202

Group type: EXPERIMENTAL
Intervention: Umbilical Cord Milking (UCM)
Number of subjects: 1780

Group type: COMPARATOR
Intervention: Early Cord Clamping (ECC)
Number of subjects: 1780
Study: 33798654

Group type: EXPERIMENTAL
Intervention: Voretigene neparvovec (VN; Luxturna) administered via bilateral subretinal injections in the original intervention group (OI).
Number of subjects: 31

Group type: COMPARATOR
Intervention: Voretigene neparvovec (VN; Luxturna) administered via bilateral subretinal injections after 1 year in the delayed intervention group (DI).
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Voretigene neparvovec (VN; Luxturna) administered in OI group.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Voretigene neparvovec (VN; Luxturna) administered in DI group.
Number of subjects: 31
Study: 32412094

Group type: EXPERIMENTAL
Intervention: VisualaseTM MRI-Guided Laser Ablation System
Number of subjects: 150
Study: 35705263

Group type: EXPERIMENTAL
Intervention: Ropivacaine group (group R) received additional SFICB using 40 mL of 0.375% ropivacaine.
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Ropivacaine group (group R)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 86
Study: 34182547

Group type: EXPERIMENTAL
Intervention: Prenatal surgical closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postnatal surgical closure
Number of subjects: 0
Study: 35803624

Group type: EXPERIMENTAL
Intervention: 250 mg daily azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 mg three-times-weekly azithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 32555025

Group type: EXPERIMENTAL
Intervention: Ahead of the Game program (intervention group)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 350
Study: 35042458

Group type: EXPERIMENTAL
Intervention: 7‐Fr central venous catheter (VC) group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional chest tube (CT) group
Number of subjects: 92
Study: 34526033

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine stat, prednisolone, azithromycin and naproxen (Group I)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Hydroxychloroquine and Lopinavir/Ritonavir (Group III)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine stat, azithromycin and naproxen (Group II)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Prednisolone (Group I)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Lopinavir/Ritonavir (Group III)
Number of subjects: 336
Study: 33370763

Group type: EXPERIMENTAL
Intervention: Model 328-based peer education intervention for 8 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 150
Study: 32772583

Group type: EXPERIMENTAL
Intervention: 12-week physical rehabilitation program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (12-week waiting period)
Number of subjects: 84
Study: 36496259

Group type: EXPERIMENTAL
Intervention: ROTEM-guided treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 34482042

Group type: EXPERIMENTAL
Intervention: Risk of Relapse Assessment Scale (RRAS)
Number of subjects: 438
Study: 32376809

Group type: EXPERIMENTAL
Intervention: Oral gargling with an aroma solution
Number of subjects: 67

Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 67
Study: 34473338

Group type: EXPERIMENTAL
Intervention: Curcuminoids treatment (exact dosage and duration not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 32970837

Group type: EXPERIMENTAL
Intervention: Late-absorbable sutures (group A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-absorbable sutures (group B)
Number of subjects: 150
Study: 32060130

Group type: EXPERIMENTAL
Intervention: Serum zonulin levels in NCGS patients
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Self-reported NCGS
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Wheat avoidance diet in HLA-DQ2/8-positive NCGS patients
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Zonulin levels diagnostic accuracy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Diagnostic algorithm combining zonulin levels, symptoms, and gender
Number of subjects: 86
Study: 615918485

Group type: EXPERIMENTAL
Intervention: Room 3.8m wide and 8m long
Number of subjects: 35

Group type: COMPARATOR
Intervention: Room 11m wide and 9m long
Number of subjects: 35
Study: 36484190

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy based on 'gut-brain axis', treated with acupuncture at specific acupoints (Touwei, Shenting, Sishencong, Tianshu, Zhongwan, Zusanli), given once every other day, 3 times a week for 4 weeks, for 3 courses.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine rehabilitation training (Control group).
Number of subjects: 66
Study: 34846698

Group type: EXPERIMENTAL
Intervention: Washed microbiota transplantation (WMT), frequency: once a day for three consecutive days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine treatment and WMT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment only
Number of subjects: 0
Study: 35747189

Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg orally on day 1, 80 mg on days 2-3) plus palonosetron (0.25 mg intravenously on day 1)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Dexamethasone (10 mg intravenously on day 1, 5 mg on days 2-3) plus palonosetron (0.25 mg intravenously on day 1)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Dexamethasone plus palonosetron
Number of subjects: 315
Study: 35066948

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.4 mg/kg, maximum 30 mg/day) intravenously for 3 days
Number of subjects: 139

Group type: COMPARATOR
Intervention: Conservative care only
Number of subjects: 139
Study: 34118562

Group type: EXPERIMENTAL
Intervention: NT‐proBNP > 1500 ?mol/L
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Left atrial to aortic root ratio >2.1
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Normalized left ventricular end‐diastolic diameter > 1.9
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Early transmitral peak velocity (E peak) > 1 m/sec
Number of subjects: 168
Study: 33172546

Group type: EXPERIMENTAL
Intervention: Phototherapy combined with Saccharomyces boulardii
Number of subjects: 124
Study: 35616109

Group type: EXPERIMENTAL
Intervention: Immediate ADT (n=56)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Delayed ADT (n=69)
Number of subjects: 261

Group type: COMPARATOR
Intervention: No prior ADT group
Number of subjects: 261
Study: 35607258

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Non-specific cognitive-training (NSCT)
Number of subjects: 56
Study: 34037772

Group type: EXPERIMENTAL
Intervention: Semi-skeletonized harvesting of the left internal mammary artery (LIMA)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Pedicled harvesting of the left internal mammary artery (LIMA)
Number of subjects: 235
Study: 36064432

Group type: EXPERIMENTAL
Intervention: HTO combined with PRP
Number of subjects: 74

Group type: COMPARATOR
Intervention: HTO combined with hyaluronic acid
Number of subjects: 74

Group type: COMPARATOR
Intervention: HTO combined with normal saline (NS)
Number of subjects: 74
Study: 35434156

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) along with routine care (CB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham ESWT along with routine care (CB)
Number of subjects: 50
Study: 34210730

Group type: EXPERIMENTAL
Intervention: GeMuKi lifestyle intervention (counselling using motivational interviewing techniques)
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: GeMuKi lifestyle intervention
Number of subjects: 1860
Study: 32457082

Group type: EXPERIMENTAL
Intervention: EPOCH bundle added to standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 0
Study: 36215327

Group type: EXPERIMENTAL
Intervention: Digital home exercise program (12-week duration, 4 exercises daily)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Physiotherapy (6 to 12 sessions depending on severity)
Number of subjects: 213